lj, I've been a dedicated investor for well over 1.5 years, and the reason for this is not just because of the two awesome world-class technologies, but because management is incomparable.
The more stocks I become involved with, the more I love my CTUM. This, mainly because dilution has never been a major problem. You will be VERY heard pressed to find another 9 yr old OTC stock that has never done an r/s and yet still only has a 34M o/s, while having no revenues to speak of.
When I first bought CTUM, I bought at .055, only to see the s/p later fall back to as low as .036, temporarily. That might not seem like much, but technically, that's a full 35%+ haircut on my money...had I sold, which natch, I didn't. I felt the risk was worth taking, so I bought more.
Those were the best decisions I've ever made in my life.
Granted, I may have been fortunate, but luck comes to those most prepared for it.
The FDA approval is presently the biggest development on CSMG's table right now, but considering that D. Robbins has hired probably one of the world's absolute best men for the job, in terms of submitting the filing, the likeliness of approval is in our favor. Again, luck comes to those most prepared for it, and the additional time it took for the filing was the 'preparation' I speak of, when putting 'luck' in our corner.
In terms of arguments regarding revenues, make no mistake, revenues or not, FDA approval will boost the CTUM shareprice several-fold, to say the least.
FDA approval will put CTUM's LTC in the ring with some mighty big boys who's staples, glues, and sealants will largely become outdated.
In terms of arguments regarding revenues, make no mistake, immediate revenues or not, FDA approval will be the license to legally drive this new this new technology into the future, and a clean driver's license is ALWAYS more valuable than NO driver's license!
News 
Market Data 
Discover 
AI
